Introducing WikiPathways to link molecular pathways to adverse outcome pathways to support regulatory risk assessment

被引:0
|
作者
Martens, M. [1 ]
Willighagen, E. [1 ]
Nymark, P. [3 ,4 ]
Grafstrom, R. [3 ,4 ]
Burgoon, L. D. [7 ]
Aladjov, H. T. [5 ]
Andon, F. Torres [6 ]
Evelo, C. T. [1 ,2 ]
机构
[1] Maastricht Univ, Bioinformat BiGCaT, Maastricht, Netherlands
[2] Maastricht Univ, Maastricht Ctr Syst Biol MaCSBio, Maastricht, Netherlands
[3] Karolinska Inst, Inst Environm Med, Solna, Sweden
[4] Misvik Biol Ltd, Toxicol, Turku, Finland
[5] Org Econ Cooperat & Dev, Environm Directorate, Paris, France
[6] Clin & Res Inst Humanitas, Lab Cellular Immonol, Milan, Italy
[7] Engn Res & Dev Ctr, Environm Lab, Vicksburg, MS USA
关键词
D O I
10.1016/j.toxlet.2018.06.962
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
P19-25
引用
收藏
页码:S227 / S228
页数:2
相关论文
共 50 条
  • [1] Introducing WikiPathways as a Data-Source to Support Adverse Outcome Pathways for Regulatory Risk Assessment of Chemicals and Nanomaterials
    Martens, Marvin
    Verbruggen, Tim
    Nymark, Penny
    Grafstrom, Roland
    Burgoon, Lyle D.
    Aladjov, Hristo
    Andon, Fernando Torres
    Evelo, Chris T.
    Willighagen, Egon L.
    FRONTIERS IN GENETICS, 2018, 9
  • [2] ADVERSE OUTCOME PATHWAYS: A CONCEPTUAL FRAMEWORK TO SUPPORT ECOTOXICOLOGY RESEARCH AND RISK ASSESSMENT
    Ankley, Gerald T.
    Bennett, Richard S.
    Erickson, Russell J.
    Hoff, Dale J.
    Hornung, Michael W.
    Johnson, Rodney D.
    Mount, David R.
    Nichols, John W.
    Russom, Christine L.
    Schmieder, Patricia K.
    Serrrano, Jose A.
    Tietge, Joseph E.
    Villeneuve, Daniel L.
    ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY, 2010, 29 (03) : 730 - 741
  • [3] Developing adverse outcome pathways to support radioecological risk assessment: challenges and insights
    Sekatcheff, Elizabeth Dufourcq
    Quevarec, Loic
    Delignette-Muller, Marie-Laure
    Car, Clement
    Bonzom, Jean-Marc
    Gilbin, Rodolphe
    Tollefsen, Knut-Erik
    Armant, Olivier
    Frelon, Sandrine
    ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY, 2025,
  • [4] Adverse Outcome Pathways are the future for regulatory toxicology
    Wallace, Heather
    Hines, Ron
    TOXICOLOGY LETTERS, 2018, 295 : S12 - S13
  • [5] Adverse outcome pathways, key events, and radiation risk assessment
    Preston, R. Julian
    Ruhm, Werner
    Azzam, Edouard, I
    Boice, John D.
    Bouffler, Simon
    Held, Kathryn D.
    Little, Mark P.
    Shore, Roy E.
    Shuryak, Igor
    Weil, Michael M.
    INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2021, 97 (06) : 804 - 814
  • [6] Using Adverse Outcome Pathways to support mechanistic based safety assessment
    Whelan, Maurice
    MUTAGENESIS, 2014, 29 (06) : 534 - 534
  • [7] Integration of Data With Adverse Outcome Pathways (AOPs) to Support Genotoxicity Assessment
    Kane, Steven
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2022, 63 : 34 - 34
  • [8] Chronic inflammation, Adverse Outcome Pathways, and risk assessment: A diagrammatic exposition
    Cox, Louis Anthony, Jr.
    Goodman, Julie E.
    Engel, Anna M.
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2020, 114
  • [9] The Role of Omics in the Application of Adverse Outcome Pathways for Chemical Risk Assessment
    Brockmeier, Erica K.
    Hodges, Geoff
    Hutchinson, Thomas H.
    Butler, Emma
    Hecker, Markus
    Tollefsen, Knut Erik
    Garcia-Reyero, Natalia
    Kille, Peter
    Becker, Doerthe
    Chipman, Kevin
    Colbourne, John
    Collette, Timothy W.
    Cossins, Andrew
    Cronin, Mark
    Graystock, Peter
    Gutsell, Steve
    Knapen, Dries
    Katsiadaki, Ioanna
    Lange, Anke
    Marshall, Stuart
    Owen, Stewart F.
    Perkins, Edward J.
    Plaistow, Stewart
    Schroeder, Anthony
    Taylor, Daisy
    Viant, Mark
    Ankley, Gerald
    Falciani, Francesco
    TOXICOLOGICAL SCIENCES, 2017, 158 (02) : 252 - 262
  • [10] Mechanistic models and adverse outcome pathways: Research needs for risk assessment
    Watanabe, Karen H.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248